VAERS Explorer
Back to explore

Report #2866116

Received Oct 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Aug 22, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK3046714IM
FLU3INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE)SANOFI PASTEURUNK——

Symptoms (1)

Oropharyngeal pain

Symptom narrative

Sometimes feel had a sore throat/oropharyngeal pain (sore throat); This spontaneous case was reported by a non-health professional and describes the occurrence of OROPHARYNGEAL PAIN (Sometimes feel had a sore throat/oropharyngeal pain (sore throat)) in a patient of an unknown age and gender who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3046714) for COVID-19 prophylaxis. Co-suspect product included non-company product Influenza vaccine inact split 3v (Fluzone high dose) for Prophylactic vaccination. Previously administered products included for COVID-19 prophylaxis: Spikevax NOS (It was reported that patient's all previous vaccines shots were Moderna.). Past adverse reactions to the above products included No adverse effect with Spikevax NOS. On 22-Aug-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter and dose of Influenza vaccine inact split 3v (Fluzone high dose) (unknown route) 1 dosage form. In 2025, the patient experienced OROPHARYNGEAL PAIN (Sometimes feel had a sore throat/oropharyngeal pain (sore throat)). At the time of the report, OROPHARYNGEAL PAIN (Sometimes feel had a sore throat/oropharyngeal pain (sore throat)) had not resolved. Concomitant medications were not reported. The patient sometimes felt a sore throat/oropharyngeal pain (sore throat) after receiving the Influenza USP Trival A-B high dose subvirion vaccine, suspension for injection in a pre-filled syringe [Fluzone high dose] and Spikevax 2024-2025 Formula. The patient's past medical treatments and family history were not provided. Information on the batch number was requested corresponding to the one at the time of event occurrence. The event latency was reported as a few days approximately. The patient did not have an effect like this before. It was the first time the patient had a negative effect to the extent that the patient was in bed all day the following day and did not know if it was the flu shot or the extra COVID shot. Regarding whether the patient was still experiencing symptoms, it was reported that it was probably a phantom thing. The patient was so upset about it. The patient sometimes felt a sore throat, when it was probably just normal. It was unknown if the patient experienced any additional symptoms/events. It was not reported if the patient received a corrective treatment for the event.